Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chabner

Showing results (101-110 of 456) with videos related to

Pageof 46
Sort By:
The Oncologist|December 17, 2009
Mysterious metforminCurtis R Chong, Bruce A Chabner
The Oncologist|September 17, 2008
One in five cancer clinical trials is published: a terrible symptom--what's the diagnosis?Gregory A Curt, Bruce A Chabner
The New England Journal of Medicine|January 21, 2026
Cerebral Folate Deficiency, Autism, and the Role of LeucovorinI David Goldman, Bruce A Chabner
The Virtual Mentor : VM|December 11, 2012
Setting fair prices for life-saving drugsBruce A Chabner, Thomas G Roberts
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Histone deacetylase inhibitors in cancer therapyAndrew A Lane, Bruce A Chabner
The Oncologist|October 25, 2018
Conflict of Interest: An Ethical Firestorm with Consequences for Cancer ResearchBruce A Chabner, Susan E Bates
The Oncologist|January 28, 2017
Let This Be Our New Year's PledgeBruce A Chabner, Martin J Murphy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2022
Joseph R. Bertino, Scientist and Clinical OncologistBruce A Chabner, George P Canellos
The Oncologist|April 19, 2018
Canakinumab and Lung Cancer: Intriguing, but Is It Real?Bruce A Chabner, Christopher S Nabel
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 5, 2002
Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal womenArmen H Tashjian, Bruce A Chabner
Pageof 46

Showing results (101-110 of 456) with videos related to

Sort By:
Pageof 46
The Oncologist|December 17, 2009
Mysterious metforminCurtis R Chong, Bruce A Chabner
The Oncologist|September 17, 2008
One in five cancer clinical trials is published: a terrible symptom--what's the diagnosis?Gregory A Curt, Bruce A Chabner
The New England Journal of Medicine|January 21, 2026
Cerebral Folate Deficiency, Autism, and the Role of LeucovorinI David Goldman, Bruce A Chabner
The Virtual Mentor : VM|December 11, 2012
Setting fair prices for life-saving drugsBruce A Chabner, Thomas G Roberts
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Histone deacetylase inhibitors in cancer therapyAndrew A Lane, Bruce A Chabner
The Oncologist|October 25, 2018
Conflict of Interest: An Ethical Firestorm with Consequences for Cancer ResearchBruce A Chabner, Susan E Bates
The Oncologist|January 28, 2017
Let This Be Our New Year's PledgeBruce A Chabner, Martin J Murphy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2022
Joseph R. Bertino, Scientist and Clinical OncologistBruce A Chabner, George P Canellos
The Oncologist|April 19, 2018
Canakinumab and Lung Cancer: Intriguing, but Is It Real?Bruce A Chabner, Christopher S Nabel
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 5, 2002
Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal womenArmen H Tashjian, Bruce A Chabner
Pageof 46